Healthcare provider profile · identity verified

June Ivey, MD

Internal Medicine · OKLAHOMA CITY, OK · NPI 1588958706

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	339	116
Levothyroxine Sodium	Levothyroxine Sodium	314	100
Amlodipine Besylate	Amlodipine Besylate	277	97
Gabapentin	Gabapentin	249	69
Omeprazole	Omeprazole	243	73
Montelukast Sodium	Montelukast Sodium	218	70
Losartan Potassium	Losartan Potassium	182	61
Hydrochlorothiazide	Hydrochlorothiazide	176	53
Rosuvastatin Calcium	Rosuvastatin Calcium	174	63
Pantoprazole Sodium	Pantoprazole Sodium	152	54
Simvastatin	Simvastatin	152	48
Lisinopril	Lisinopril	151	46
Metoprolol Succinate	Metoprolol Succinate	126	43
Sertraline Hcl	Sertraline Hcl	115	34
Albuterol Sulfate Hfa	Albuterol Sulfate	113	42
Alprazolam	Alprazolam	110	26
Metformin Hcl	Metformin Hcl	103	34
Famotidine	Famotidine	100	27
Ozempic	Semaglutide	100	22
Potassium Chloride	Potassium Chloride	99	38
Bupropion Xl	Bupropion Hcl	97	20
Pravastatin Sodium	Pravastatin Sodium	97	30
Duloxetine Hcl	Duloxetine Hcl	89	24
Fluticasone Propionate	Fluticasone Propionate	82	35
Zolpidem Tartrate	Zolpidem Tartrate	81	14
Furosemide	Furosemide	79	29
Meloxicam	Meloxicam	77	28
Escitalopram Oxalate	Escitalopram Oxalate	76	26
Trazodone Hcl	Trazodone Hcl	73	21
Metoprolol Tartrate	Metoprolol Tartrate	71	24
Tamsulosin Hcl	Tamsulosin Hcl	70	20
Amitriptyline Hcl	Amitriptyline Hcl	64	22
Clopidogrel	Clopidogrel Bisulfate	62	18
Pregabalin	Pregabalin	62	14
Tizanidine Hcl	Tizanidine Hcl	62	31
Carvedilol	Carvedilol	61	24
Buspirone Hcl	Buspirone Hcl	60	18
Hydroxyzine Hcl	Hydroxyzine Hcl	57	23
Eliquis	Apixaban	56	20
Januvia	Sitagliptin Phosphate	54	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	23
Spironolactone	Spironolactone	51	22
Metformin Hcl Er	Metformin Hcl	50	18
Fluoxetine Hcl	Fluoxetine Hcl	48	suppressed
Allopurinol	Allopurinol	47	16
Estradiol	Estradiol	46	15
Prednisone	Prednisone	46	34
Venlafaxine Hcl Er	Venlafaxine Hcl	45	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	14
Atenolol	Atenolol	41	15
Bupropion Hcl Sr	Bupropion Hcl	41	15
Breo Ellipta	Fluticasone/Vilanterol	40	11
Glipizide	Glipizide	40	14
Hydralazine Hcl	Hydralazine Hcl	40	14
Methylprednisolone	Methylprednisolone	39	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	13
Ezetimibe	Ezetimibe	37	14
Topiramate	Topiramate	36	13
Doxycycline Hyclate	Doxycycline Hyclate	35	32
Irbesartan	Irbesartan	34	11
Mounjaro	Tirzepatide	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	16
Ibuprofen	Ibuprofen	33	15
Tramadol Hcl	Tramadol Hcl	33	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Promethazine Hcl	Promethazine Hcl	31	11
Azelastine Hcl	Azelastine Hcl	30	15
Hydroxyzine Pamoate	Hydroxyzine Pamoate	30	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	13
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Doxepin Hcl	Doxepin Hcl	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	12
Premarin	Estrogens, Conjugated	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Diazepam	Diazepam	23	suppressed
Colestipol Hcl	Colestipol Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Celecoxib	Celecoxib	21	11
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Baclofen	Baclofen	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Naproxen	Naproxen	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Nystatin	Nystatin	18	suppressed
Torsemide	Torsemide	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Finasteride	Finasteride	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Cefdinir	Cefdinir	16	14
Eszopiclone	Eszopiclone	16	suppressed
Ketoconazole	Ketoconazole	16	11
Azithromycin	Azithromycin	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Fluconazole	Fluconazole	15	14
Jardiance	Empagliflozin	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Novolog Flexpen	Insulin Aspart	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Promethegan	Promethazine Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Glipizide Er	Glipizide	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Risperidone	Risperidone	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error